Hypomagnesemia: An evidence-based approach to clinical cases

Iranian Journal of Kidney Diseases

Volumn 4, Issue 1, 2010, Pages 13-19

  Assadi, Farahnak ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Bartter syndrome; Gitelman syndrome; Hypomagnesemia; Metabolic diseases

Indexed keywords

ALENDRONIC ACID; AMILORIDE; LOOP DIURETIC AGENT; MAGNESIUM; MAGNESIUM SULFATE; SODIUM CHLORIDE COTRANSPORTER; THIAZIDE DIURETIC AGENT; THYROXINE;

CLINICAL FEATURE; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; GITELMAN SYNDROME; GRAND MAL SEIZURE; HUMAN; HYPOMAGNESEMIA; KIDNEY FUNCTION; MAGNESIUM EXCRETION; METABOLIC DISORDER; MUSCLE WEAKNESS; REVIEW; TETANY; URINALYSIS;

EDUCATION, MEDICAL, CONTINUING; EVIDENCE-BASED MEDICINE; GITELMAN SYNDROME; HUMANS; MAGNESIUM; MAGNESIUM DEFICIENCY;

EID: 75649130812     PISSN: 17358582     EISSN: 17358604     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Whang R, Hampton EM, Whang DD. Magnesium homeostasis and clinical disorders of magnesium deficiency. Ann Pharmacother. 1994;28:220-5.
2. Drueke TB, Lacour B. Magnesium homeostasis and disorders of magnesium metabolism. In: Feehally J, Floege J, Johnson RJ, editors. Comprehensive clinical nephrology. 3rd ed. Philadelphia: Mosby; 2007. p. 136-8.
3. Augus ZS. Hypomagnesemia. J Am Soc Nephrol. 1999;10:1616-22.
4. Kelepouris E, Agus ZS. Hypomagnesemia: renal magnesium handling. Semin Nephrol. 1998;18:58-73.
5. Fine KD, Santa Ana CA, Porter JL, Fordtran JS. Intestinal absorption of magnesium from food and supplements. J Clin Invest. 1991;88:396-402.
6. Brasier AR, Nussbaum SR. Hungry bone syndrome: clinical and biochemical predictors of its occurrence after parathyroid surgery. Am J Med. 1988;84:654-60.
7. Konrad M, Weber S. Recent advances in molecular genetics of hereditary magnesium-losing disorders. J Am Soc Nephrol. 2003;14:249-60.
8. Konrad M, Schlingmann KP, Gudermann T. Insights into the molecular nature of magnesium homeostasis. Am J Physiol Renal Physiol. 2004;286:F599-605.
9. Shah GM, Kirschenbaum MA. Renal magnesium wasting associated with therapeutic agents. Miner Electrolyte Metab. 1991;17:58-64.
10. + channel abundance explains thiazide-induced hypocalciuria and hypomagnesemia. J Clin Invest. 2005;115:1651-8.
11. Foster JE, Harpur ES, Garland HO. An investigation of the acute effect of gentamicin on the renal handling of electrolytes in the rat. J Pharmacol Exp Ther.1992:261:38-43.
12. +) transport proteins in the kidney explains tacrolimus (FK506)-induced hypercalciuria and hypomagnesemia. J Am Soc Nephrol. 2004;15:549-57.
13. Ettinger LJ, Gaynon PS, Krailo MD, Ru N, Baum ES, Hammond GD. A phase II study of carboplatin in children with recurrent or progressive solid tumors. Cancer. 1994;73:1297-301.
14. Epstein M, McGrath S, Law F. Proton-pump inhibitors and hypomagnesemic hypoparathyroidism. N Engl J Med. 2006;355:1834-6.
15. Cole DE, Quamme GA. Inherited disorders of renal magnesium handling. J Am Soc Nephrol. 2000;11: 1937-47.
16. Takeuchi K, Kure S, Kato T, et al. Association of a mutation in thiazide-sensitive Na-Cl cotransporter with familial Gitelman's syndrome. J Clin Endocrinol Metab.1996;12:4496-9.
17. Riveira-Munoz E, Chang Q, Godefroid N, et al. Transcriptional and functional analyses of SLC12A3 mutations: new clues for the pathogenesis of Gitelman syndrome. J Am Soc Nephrol. 2007;18:1271-83.
18. Cruz DN, Shaer AJ, Bia MJ, Lifton RP, Simon DB. Gitelman's syndrome revisited: an evaluation of symptoms and health-related quality of life. Yale Gitelman's and Bartter's syndrome Study Group. Kidney Int. 2001;59: 710-17.
19. Simon DB, Karet FE, Hamdan JM, DiPietro A, Sanjad SA, Lifton RP. Bartter's syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2. Nat Genet. 1996;13:183-8.
20. Konrad M, Vollmer M, Lemmink HH, et al. Mutations in the chloride channel gene CLCNKB as a cause of classic Bartter syndrome. J Am Soc Nephrol. 2000;11:1449-59.
21. Simon DB, Karet FE, Rodriquez-Soriano J, et al. Genetic heterogeneity of Bartter's syndrome revealed by mutations in the K+ channel, ROMK. Nat Genet. 1996;14:152-6.
22. Brennan TM, Landau D, Shalev H, et al. Linkage of infantile Bartter syndrome with sensorineural deafness to chromosome 1p. Am J Hum Genet. 1998;62:355-61.
23. Praga M, Vara J, Gonzalez-Parra E, et al. Familial hypomagnesemia with hypercalciuria and nephrocalcinosis. Kidney Int. 1995;47:1419-25.
24. Nicholson JC, Jones CL, Powell HR, Walker RG, McCredie DA. Familial hypomagnesaemia - hypercalciuria leading to end stage renal failure. Pediatr Nephrol. 1995;9:74-6.
25. Weber S, Schneider L, Peters M, et al. Novel paracellin-1 mutations in 25 families with familial hypomagnesemia with hypercalciuria and nephrocalcinosis. J Am Soc Nephrol. 2001;12:1872-81.
26. Okazaki R, Chikatsu N, Nakatsu M, et al. A novel activating mutation in calcium-sensing receptor gene associated with a family of autosomal dominant hypocalcemia. J Clin Endocrinol Metab. 1999;84:363-6.
27. Geven WB, Monnens LA, Willems HL, Buijs WC, Ter Haar BG. Renal magnesium wasting in two families with autosomal dominant inheritance. Kidney Int.1987;31:1140-4.
28. Geven WB, Monnens LA, Willems JL, Buijs W, Hamel CJ. Isolated autosomal recessive renal magnesium loss in two sisters. Clin Genet. 1987;32:398-402.
29. Whang R, Whang DD, Ryan MP. Refractory potassium depletion. A consequence of magnesium deficiency. Arch Intern Med. 1992;152:40-5.
30. Shoback D. Clinical Practice. Hypoparathyroidism. N Engl J Med. 2008;359:391-403.
31. Dyckner T. Serum magnesium in acute myocardial infarction. Relation to arrhythmias. Acta Med Scand. 1980;207:59-66.
32. Vallee B, Wacker WE, Ulmer DD. The magnesium deficiency tetany syndrome in man. N Engl J Med. 1960;262:155-61.
33. Elisaf M, Panteli K, Theodorou J, Siamopoulos KC. Fractional excretion of magnesium in normal subjects and in patients with hypomagnesemia. Magnes Res. 1997;10:315-20.
34. Bettinelli A, Bianchetti MG, Girardin E, et al. Use of calcium excretion values to distinguish two forms of primary renal tubular hypokalemic alkalosis: Bartter and Gitelman syndromes. J Pediatr. 1992;120:38-43.
35. Assadi F. Disorders of divalent ion metabolism. In: Assadi F, editor. Clinical decisions in pediatric nephrology: a problem-solving approach to clinical cases. New York: Springer; 2008. p. 97-123.